Touchstone Capital, Inc. Pfizer Inc Transaction History

Touchstone Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $3,131 - $4,087	-75 Reduced 1.64%	4,504 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $28,181 - $34,402	-644 Reduced 12.33%	4,579 $200,000
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $2,373 - $2,813	-51 Reduced 0.97%	5,223 $274,000
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $57,370 - $71,089	1,254 Added 31.19%	5,274 $273,000
Q4 2021 Jan 26, 2022	BUY	$41.32 - $61.25 $166,106 - $246,225	4,020 New	4,020 $237,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Touchstone Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Touchstone Capital, Inc. with notifications on news.